Cargando…
PNN and KCNQ1OT1 Can Predict the Efficacy of Adjuvant Fluoropyrimidine-Based Chemotherapy in Colorectal Cancer Patients
The benefit of adjuvant chemotherapy in the early stages of colorectal cancer (CRC) is still disappointing and the prediction of treatment outcome quite difficult. Recently, through a transcriptomic approach, we evidenced a role of PNN and KCNQ1OT1 gene expression in predicting response to fluoropyr...
Autores principales: | Lapucci, Andrea, Perrone, Gabriele, Di Paolo, Antonello, Napoli, Cristina, Landini, Ida, Roviello, Giandomenico, Calosi, Laura, Naccarato, Antonio Giuseppe, Falcone, Alfredo, Bani, Daniele, Mini, Enrico, Nobili, Stefania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962934/ https://www.ncbi.nlm.nih.gov/pubmed/33208224 http://dx.doi.org/10.3727/096504020X16056983169118 |
Ejemplares similares
-
KCNQ1OT1 polymorphism rs35622507 and methylation status of KCNQ1OT1 promoter influence the drug resistance to L-OHP
por: Zhang, Caihong, et al.
Publicado: (2022) -
Selection and characterization of a human ovarian cancer cell line resistant to auranofin
por: Landini, Ida, et al.
Publicado: (2017) -
The Inhibitory Effects of HYDAMTIQ, a Novel PARP Inhibitor, on Growth in Human Tumor Cell Lines With Defective DNA Damage Response Pathways
por: Mini, Enrico, et al.
Publicado: (2017) -
KCNQ1OT1 promotes melanoma growth and metastasis
por: Guo, Bingyu, et al.
Publicado: (2018) -
KCNQ1OT1: An Oncogenic Long Noncoding RNA
por: Cagle, Patrice, et al.
Publicado: (2021)